info@thelaunchport.com
Get Started

Author: Bob Storey

Back to All News & Insights

Materic and LaunchPort Announce Partnership to Drive Advanced Materials Manufacturing for Medical Device Technology

Jul 17, 2022

Materic’s expertise in advanced materials and 3D printing to combine with The LaunchPort’s skills in GMP production of medical devices and technologies   July 18, 2022, Baltimore, MD – Materic, a custom manufacturer of advanced materials, and LaunchPort, LLC, a medical device venture center and GMP contract manufacturing operation today announced a partnership to drive the […]

Read More

LaunchPort Announces New Partnerships with Residents to Promote Diagnostic Device Development

Jul 12, 2022

LaunchPort is announcing a new partnership in conjunction with their Resident companies to offer design, prototyping and commercial assessment for technology innovators in the diagnostics space.  For those developers that are in the early to intermediate stages of commercialization or translation, this expertise and access to these development tools can be a critical multiplier in […]

Read More

LaunchPort expands Manufacturing, Supply Chain, Ventures, and Consulting Activities

May 28, 2022

During late 2021, Indianapolis based Engineered Medical Systems and Pulmodyne, Inc., owners/operators of Engineered Medical Systems – Baltimore, were acquired by Intrasurgical UK. (https://www.ibj.com/articles/pulmodyne-inc-is-acquired-by-british-respiratory-device-maker). At that time the LaunchPort LLC partners, Bob Storey and Jeff Quinn, acquired the Baltimore manufacturing operation and integrated it into LaunchPort as a wholly owned subsidiary.  The site was re-registered […]

Read More

LaunchPort’s Novel Microdevices Lands Important Funding from Carb-X Global Partnership

Apr 6, 2021

Novel Microdevices (https://noveldx.com/) was awarded up to $13.8 million from CARB-X (https://carb-x.org/) for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections such as Chlamydia trachomatis and Neisseria gonorrhoeae. Novel’s new device would diagnose infections in about 25 minutes from a vaginal swab or urine sample, and […]

Read More

Details of Construction Elements Outlined in Port Covington Plans

Mar 29, 2021

The next five buildings in Port Covington are scheduled to begin delivering in late 2022. This development phase will have 440,000 sq. ft. of office; 586,000 sq. ft. of residential from 537 total housing units which break down as 367 market-rate residential dwelling units, 89 affordable dwelling units (ADU), and 81 extended-stay units; 116,000 sq. […]

Read More

Port Covington developers, state officials celebrate start of vertical construction in South Baltimore

Mar 26, 2021

Renderings of the future neighborhood show foot traffic bustling around the parks, shops and eateries. Central to the design is Rye Street Market, a large, mixed-use office building and food hub designed with Baltimore’s rich legacy of open-air markets. Designs also feature breweries, “extended stay” units, wide sidewalks and entertainment venues. The neighborhood is currently […]

Read More

Podcast by Ready Robotics CEO Ben Gibbs

Mar 15, 2021

LaunchPort Resident discusses history, growth and future outlook of Ready Robotics on “Automating the Chain” talk show.  In this episode, Tee sits down with Benjamin Gibbs, Co-Founder and CEO of READY Robotics to talk about making robotics user-friendly to spark the future of industrial automation. https://www.automatingthechain.com/podcast/18-democratizing-access-to-robotics/ Automating The Chain bridges the learning gap between business executives […]

Read More

The LaunchPort virtual resident Brevitest moves closer to launch of COVID-19 Antibody test

Sep 4, 2020

BreviTest Technologies announced that the FDA has officially accepted BreviTest’s notification of its intent to commercially distribute its IgG antibody test.  The BreviTest SARS-CoV-2 IgG Test detects the presence of SARS-CoV-2 specific IgG antibodies in plasma or serum using only 3μl of sample. Reliable results are available in 10 minutes. A positive test result indicates prior […]

Read More

CoapTech Closes $7M Series B Investment

Sep 2, 2020

CoapTech announced the closing of a Series B investment of $7 million led by medical device venture capital firm Hunniwell Lake Ventures. They will use funds to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement. News Article

Read More
1 2 3 4
Get Started

Let’s build something together.

The LaunchPort | Copyright 2020 | All rights reserved